Evidence map›Paper›PMID 39330896›Full record

ArticleTropical medicine and infectious disease2024

Effects of Five Years of Treatment of Onchocerciasis with Ivermectin under Community Guidelines in Resurgent Areas of Burkina Faso: A before-and-after Analysis.

Micheline O Ouedraogo, Ivlabèhirè Bertrand Meda, Karifa Kourouma, Fanny Yago Wienne, Dieudonné Nare, Clarisse Bougouma, Justin Compaore, Seni Kouanda

Abstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Micheline O OuedraogoHelen Keller International, Ouagadougou 06 P.O. Box 9515, Burkina Faso.
Ivlabèhirè Bertrand MedaAfrican Institute of Public Health (IASP), Ouagadougou 12 P.O. Box 199, Burkina Faso.ORCID 0000-0002-9717-3770
Karifa KouroumaNational Center for Training and Research in Rural Health of Maferinyah (CNFRSR), Maferinyah P.O. Box 2649, Guinea.ORCID 0000-0001-6375-262X
Fanny Yago WienneHelen Keller International, Ouagadougou 06 P.O. Box 9515, Burkina Faso.
Dieudonné NareHelen Keller International, Ouagadougou 06 P.O. Box 9515, Burkina Faso.
Clarisse BougoumaNational Program for the Control of Neglected Tropical Diseases, Ouagadougou 06 P.O. Box 9515, Burkina Faso.
Justin CompaoreNational Program for the Control of Neglected Tropical Diseases, Ouagadougou 06 P.O. Box 9515, Burkina Faso.
Seni KouandaAfrican Institute of Public Health (IASP), Ouagadougou 12 P.O. Box 199, Burkina Faso.ORCID 0000-0003-2426-7669

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlmost the entire country of Burkina Faso was endemic to onchocerciasis. Onchocerciasis control efforts thus brought the prevalence of METHODOLOGY: We conducted a paired pre-post study using aggregated village-level data from two cross-sectional surveys conducted in each region. A Wilcoxon signed-rank test was used to compare the standardized microfilarodermia prevalence and community microfilarial load (CMFL).

resultsA total of 43 villages in 6 health districts, in the Southwest (18) and Cascades (25) regions were included in the study. The key findings were that standardized microfilaria prevalence and CMFL decreased significantly after the implementation of CDTI in both regions (

conclusionOur results thus show that the implementation of effective CDTI could stop the transmission of

Indexed as

Burkina Fasocommunity guidelinescommunity microfilarial loadivermectinmicrofilarodermiaonchocerciasisresurgent areasstandardized prevalence

Identifiers

PMID39330896
PMCPMC11435634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.